Abstract:Background Cellular response to pharmacological action of drugs is significant for drug development. Traditional detection method for cellular response to drugs normally rely on cell proliferation assay and metabolomics examination. In principle, these analytical methods often required cell labeling, invasion analysis, and hours of co-culture with drugs, which are relatively complex and time-consuming. Moreover, these methods can only indicate the drug effectiveness on cell colony rather than single cells. Thus, to meet the requirements of personal precision medicine, the development of drug response analysis on the high resolution of single cell is demanded. Results To provide precise result for drug response on single-cell level, a microfluidic platform coupled with the label-free hyperspectral imaging was developed. With the help of horizontal single-cell trapping sieves, hundreds of single cells were trapped independently in microfluidic channels for the purposes of real-time drug delivery and single-cell hyperspectral image recording. To significantly identify the cellular hyperspectral change after drug stimulation, the differenced single-cell spectrum was proposed. Compared with the deep learning classification method based on hyperspectral images, an optimal performance can be achieved by the classification strategy based on differenced spectra. And the cellular response to different reagents, for example, K + , Epidermal Growth Factor (EGF), and Gefitinib at different concentrations can be accurately characterized by the differenced single-cell spectra analysis. Significance and novelty The high-throughput, rapid analysis of cellular response to drugs at the single-cell level can be accurately performed by our platform. After systematically analyzing the materials and the structures of the single-cell microfluidic chip, the optimal single-cell trapping method was proposed to contribute to the further application of hyperspectral imaging on microfluidic single-cell analysis. And the hyperspectral characterization of single-cell with cancer drug stimulation proved the application potential of our method in personal cancer medication.

Unraveling the Drug Response Heterogeneity with Single-Cell Vibrational Phenomics

VIBRANT: Spectral Profiling for Single-Cell Drug Responses

A Proteomic Landscape of Pharmacologic Perturbations for Functional Relevance

Integrative Pharmacogenomics Analysis of Patient-Derived Xenografts

Single-Cell Multimodal Analytical Approach by Integrating Raman Optical Tweezers and RNA Sequencing

Analysis of cellular response to drugs with a microfluidic single-cell platform based on hyperspectral imaging

Achieving a Deeper Understanding of Drug Metabolism and Responses Using Single-Cell Technologies

Deciphering single-cell gene expression variability and its role in drug response

Kinetic cellular phenotypic profiling: prediction, identification, and analysis of bioactive natural products.

scPharm: identifying pharmacological subpopulations of single cells for precision medicine in cancers

In Vitro Anticancer Drug Sensitivity Sensing Through Single-Cell Raman Spectroscopy

Scstatedynamics: Deciphering the Drug-Responsive Tumor Cell State Dynamics by Modeling Single-Cell Level Expression Changes

Recent Advancements in Single-Cell Metabolic Analysis for Pharmacological Research

Identifying Modulators of Cellular Responses by Heterogeneity-sequencing

Anti-Cancer Drug Sensitivity Assay with Quantitative Heterogeneity Testing Using Single-Cell Raman Spectroscopy

Measuring Drug Response with Single-Cell Growth Rate Quantification

Therapeutic algebra of immunomodulatory drug responses at single-cell resolution

Quantitative chemometric phenotyping of three-dimensional liver organoids by Raman spectral imaging

Therapeutic Response-Based Reclassification of Multiple Tumor Subtypes Reveals Intrinsic Molecular Concordance of Therapy Across Histologically Disparate Cancers

VIBRANT: mapping cell phenotypes using vibrational spectroscopy

Landscapes of cellular phenotypic diversity in breast cancer xenografts and their impact on drug response